Description
The Department of Veterans Affairs (VA) plans to award a sole source contract to Valneva USA, Inc. for the Japanese Encephalitis Virus Vaccine (IXIARO). The vaccine is needed for Navy recruits before they leave for training, as they may be deployed to areas where Japanese Encephalitis is common. The contract is for a firm-fixed-price delivery order, and the estimated value of the proposed action is not explicitly stated. Key points about the job include:
* The vaccine is used to protect against Japanese Encephalitis, a serious disease caused by a virus found mostly in Asia and parts of the western Pacific.
* The vaccine is approved for use in individuals 2 months of age and older.
* The VA has determined that the price of the vaccine is fair and reasonable, and that the order represents the best value and results in the lowest overall cost alternative to meet the Government’s needs.